Sign in Register

Drug class

Aminocaproic Acid

Aminocaproic acid is a specific active drug ingredient rather than a formal therapeutic class; clinically, it is categorized within the antifibrinolytic class of hemostatic agents. Read more about Aminocaproic Acid

19 drugs in this class 18 manufacturers

Related classes & indications

Calcium Channel BlockersCardiovascular & renal · 344 prescription drugs Angiotensin II Receptor Antagonists (ARBs)Cardiovascular & renal · 281 prescription drugs

Showing 1–9 of 19 drugs

Sort

AMICAR (aminocaproic acid)

AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1

CLOVER PHARMACE

AMICAR (aminocaproic acid)

AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1

CLOVER PHARMACE

AMINOCAPROIC ACID

AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1

Hospira

AMINOCAPROIC ACID

AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1

VITRUVIAS THERA

AMINOCAPROIC ACID

AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1

Amneal Pharmaceuticals

AMINOCAPROIC ACID

AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1

AMERICAN REGENT

AMINOCAPROIC ACID

AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1

Major Pharamceuticals

AMINOCAPROIC ACID

AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1

CAMBER PHARMACE

AMINOCAPROIC ACID

AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1

TRUPHARMA, LLC.

Filter & compare in the drug finder → Opens the drug finder with Aminocaproic Acid preselected. Add indication or manufacturer filters there.

About Aminocaproic Acid.

Aminocaproic acid is a specific active drug ingredient rather than a formal therapeutic class; clinically, it is categorized within the antifibrinolytic class of hemostatic agents.

It functions as a synthetic lysine analogue that competitively binds to the lysine-binding sites on plasminogen, thereby inhibiting plasminogen activation and preventing fibrin degradation to stabilize formed blood clots.

Aminocaproic acid is primarily utilized to manage and prevent acute or excessive hemorrhage in clinical settings where hyperfibrinolysis contributes to bleeding, such as during cardiac surgery, dental procedures in patients with coagulopathies, and severe trauma.

fda.gov
Aminocaproic acid is a specific active drug ingredient rather than a formal therapeutic class; clinically, it is categorized within the antifibrinolytic class of hemostatic agents It functions as a synthetic lysine analogue that competitively binds to the lysine-binding sites on plasminogen, thereby inhibiting plasminogen activation and preventing fibrin degradation to stabilize formed blood clots
fda.gov
Aminocaproic acid is a specific active drug ingredient rather than a formal therapeutic class; clinically, it is categorized within the antifibrinolytic class of hemostatic agents
nih.gov
Aminocaproic acid is a specific active drug ingredient rather than a formal therapeutic class; clinically, it is categorized within the antifibrinolytic class of hemostatic agents
fda.gov
It functions as a synthetic lysine analogue that competitively binds to the lysine-binding sites on plasminogen, thereby inhibiting plasminogen activation and preventing fibrin degradation to stabilize formed blood clots
fda.gov
It functions as a synthetic lysine analogue that competitively binds to the lysine-binding sites on plasminogen, thereby inhibiting plasminogen activation and preventing fibrin degradation to stabilize formed blood clots Aminocaproic acid is primarily utilized to manage and prevent acute or excessive hemorrhage in clinical settings where hyperfibrinolysis contributes to bleeding, such as during cardiac surgery, dental procedures in patients with coagulopathies, and severe trauma